Approximately 25% of US adults are estimated to have hypertriglyceridemia (triglyceride
[TG] level≥ 150 mg/dL [≥ 1.7 mmol/L]). Elevated TG levels are associated with increased …

Triglycerides represent 1 component of a heterogeneous pool of triglyceride-rich
lipoproteins (TGRLs). The reliance on triglycerides or TGRLs as cardiovascular disease …

Even at low-density lipoprotein cholesterol (LDL-C) goal, patients with cardiometabolic
abnormalities remain at high risk of cardiovascular events. This paper aims (i) to critically …

Recent advances in human genetics, together with a large body of epidemiologic,
preclinical, and clinical trial results, provide strong support for a causal association between …

Despite the well-established benefits of statin treatments in lowering low-density lipoprotein
cholesterol (LDL-C), a significant residual risk for atherosclerotic cardiovascular disease …

Multivariate analysis of epidemiological data has often shown that elevated plasma
triglyceride (TG) concentration is not an independent risk factor for coronary heart disease …

Cardiovascular disease (CVD) is still the leading cause of death globally, and
atherosclerosis is the main pathological basis of CVDs. Low-density lipoprotein cholesterol …

Hypertriglyceridemia is a prevalent risk factor for cardiovascular disease (CVD) and
increasingly important in the setting of current obesity and insulin resistance epidemics …

Scientific interest in triglyceride-rich lipoproteins has fluctuated over the past many years,
ranging from beliefs that these lipoproteins cause atherosclerotic cardiovascular disease …

Aims The strength of the relationship of triglyceride-rich lipoproteins (TRL) with risk of
coronary heart disease (CHD) compared with low-density lipoprotein (LDL) is yet to be …